Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    18321465 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Intravitreal Injections of rhuFab V2 in Combination With Visudyne in Subjects With Age Related Macular Degeneration (AMD)
Condition: Age-Related Maculopathy
Intervention: Drug: rhuFab V2 (ranibizumab)

Study has passed its completion date and status has not been verified in more than two years.